Evaluating Use of Deferasirox as Compared to Deferoxamine in Treating Cardiac Iron Overload

NCT00600938 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

197

Enrollment

INDUSTRY

Sponsor class

Conditions

Transfusional Iron Overload
Transfusional Hemosiderosis

Interventions

DRUG: Core Study: Deferasirox
DRUG: Core Study: Deferoxamine
DRUG: Extension: deferoxamine to deferasirox
DRUG: Extension: deferasirox to deferoxamine
DRUG: Deferasirox
DRUG: Deferoxamine

Sponsor

Novartis Pharmaceuticals